ATE399159T1 - Silanester und silaneamide von 2-oxothiazolidin-4-carbonsäureamide und deren verwendung zur vorbeugung der lichtbedingten hautalterung - Google Patents

Silanester und silaneamide von 2-oxothiazolidin-4-carbonsäureamide und deren verwendung zur vorbeugung der lichtbedingten hautalterung

Info

Publication number
ATE399159T1
ATE399159T1 AT05802359T AT05802359T ATE399159T1 AT E399159 T1 ATE399159 T1 AT E399159T1 AT 05802359 T AT05802359 T AT 05802359T AT 05802359 T AT05802359 T AT 05802359T AT E399159 T1 ATE399159 T1 AT E399159T1
Authority
AT
Austria
Prior art keywords
silanesters
silaneamids
oxothiazolidine
preventing
carbonic acid
Prior art date
Application number
AT05802359T
Other languages
German (de)
English (en)
Inventor
Karine Lucet-Levannier
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Application granted granted Critical
Publication of ATE399159T1 publication Critical patent/ATE399159T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
AT05802359T 2004-10-21 2005-09-27 Silanester und silaneamide von 2-oxothiazolidin-4-carbonsäureamide und deren verwendung zur vorbeugung der lichtbedingten hautalterung ATE399159T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0452399A FR2877004B1 (fr) 2004-10-21 2004-10-21 Esters et amides silaniques d'acide 2-oxothiazolidine-4- carboxylique et leurs utilisations cosmetiques.
US63254104P 2004-12-03 2004-12-03

Publications (1)

Publication Number Publication Date
ATE399159T1 true ATE399159T1 (de) 2008-07-15

Family

ID=34950806

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05802359T ATE399159T1 (de) 2004-10-21 2005-09-27 Silanester und silaneamide von 2-oxothiazolidin-4-carbonsäureamide und deren verwendung zur vorbeugung der lichtbedingten hautalterung

Country Status (8)

Country Link
US (1) US7795286B2 (OSRAM)
EP (1) EP1805153B1 (OSRAM)
JP (1) JP5149011B2 (OSRAM)
AT (1) ATE399159T1 (OSRAM)
DE (1) DE602005007764D1 (OSRAM)
ES (1) ES2308565T3 (OSRAM)
FR (1) FR2877004B1 (OSRAM)
WO (1) WO2006045639A1 (OSRAM)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2606565C (en) 2005-05-27 2016-05-10 The University Of North Carolina At Chapel Hill Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
EP1968609A4 (en) * 2005-12-20 2010-06-09 Silamed Inc PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THE USE OF HIGHLY LIPOPHILIC SULFHYDRYL COMPOUNDS
FR2921257B1 (fr) * 2007-09-21 2009-11-06 Exsymol Sa Utilisation topique de derives thiazolidines contre les consequences du stress oxydatif de la peau
FR2940615B1 (fr) 2008-12-30 2011-12-30 Oreal Association de monosaccharides avec des agents antioxydants et son utilisation en cosmetique
BR112012003804B1 (pt) 2009-08-21 2019-02-19 Novan, Inc. Curativo para ferimentos, método para formar um curativo para ferimentos, e, kit de curativo para ferimento
CN102711729B (zh) 2009-08-21 2015-04-01 诺万公司 局部用凝胶
AU2011227198A1 (en) * 2010-03-17 2012-10-04 Arbonne International Llc Topical skin care composition
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
WO2012118829A2 (en) 2011-02-28 2012-09-07 Novan, Inc. Tertiary s-nitrosothiol-modified nitricoxide-releasing xerogels and methods of using the same
US9132725B2 (en) 2011-05-09 2015-09-15 Cummins Inc. Vehicle and hybrid drive system
US10239847B1 (en) 2016-03-03 2019-03-26 Cellactin Method for 2-oxothiazolidine-4-carboxylic acid for cellular glutathione
JP7118591B2 (ja) 2017-02-28 2022-08-16 ロレアル レゾルシノール又はその誘導体を含む組成物
JP7412898B2 (ja) 2019-04-26 2024-01-15 ロレアル 特異な粒子と親油性抗酸化剤との組み合わせ
JP7612326B2 (ja) 2019-12-16 2025-01-14 ロレアル 特定の成分の組合せを含む安定な組成物
KR20240099313A (ko) 2021-12-20 2024-06-28 로레알 레티노이드를 포함하는 안정한 조성물
FR3131845B1 (fr) 2022-01-19 2024-11-01 Oreal Composition stable comprenant un rétinoïde
FR3131837B1 (fr) 2022-01-19 2024-10-04 Oreal Composition stable comprenant un rétinoïde et un composé acide ascorbique
EP4452190A1 (en) 2021-12-20 2024-10-30 L'oreal Stable composition comprising retinoid and ascorbic acid compound
EP4637675A1 (en) 2022-12-20 2025-10-29 L'oreal Composition comprising hyaluronic acid-based polyion complex and hydrophilic or lipophilic antioxidant
FR3145279A1 (fr) 2023-01-30 2024-08-02 L'oreal Composition comprenant un complexe polyionique à base d’acide hyaluronique et un antioxydant lipophile
WO2024135577A1 (en) 2022-12-23 2024-06-27 L'oreal Stable dispersion composition comprising retinoid
FR3145278A1 (fr) 2023-01-30 2024-08-02 L'oreal Composition de dispersion stable comprenant un rétinoïde
FR3148912A1 (fr) 2023-05-24 2024-11-29 L'oreal Composition comprenant des polymères cationiques et anioniques
FR3152226B3 (fr) 2023-08-25 2025-09-19 Oreal Composition cosmétique anhydre pour une application douce et peu grasse

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208249A (en) * 1992-08-20 1993-05-04 Clintec Nutrition Co. Method for stimulating intracellular synthesis of glutathione using esters of L-2-oxothiazolidine-4-carboxylate
FR2854160B1 (fr) * 2003-04-25 2005-06-17 Oreal Nouveaux derives heterocycliques de l'acide 2-oxothiazolidine4-carboxylique, utilisation comme agent de photoprotection active

Also Published As

Publication number Publication date
US7795286B2 (en) 2010-09-14
US20090074682A1 (en) 2009-03-19
FR2877004B1 (fr) 2007-03-09
EP1805153A1 (en) 2007-07-11
EP1805153B1 (en) 2008-06-25
DE602005007764D1 (de) 2008-08-07
ES2308565T3 (es) 2008-12-01
JP2008517030A (ja) 2008-05-22
FR2877004A1 (fr) 2006-04-28
WO2006045639A1 (en) 2006-05-04
JP5149011B2 (ja) 2013-02-20

Similar Documents

Publication Publication Date Title
ATE399159T1 (de) Silanester und silaneamide von 2-oxothiazolidin-4-carbonsäureamide und deren verwendung zur vorbeugung der lichtbedingten hautalterung
AR038379A1 (es) Esteres de acidos fluoreno-carboxilicos, procedimientos para su preparacion asi como su utilizacion en calidad de medicamentos
CO5611113A2 (es) Tripeptidos que poseen un eter de hidroxiprolina de una quinolina sustituida para la inhibicion de ns3 (hepatitis c)
CY1107168T1 (el) Παραγωγα φαινυλοαλκανοϊκου οξεος και φαινυλοξυαλκανοϊκου οξεος ως ενεργοποιηται hppar
DE10190550D2 (de) Kosmetische Zusammensetzung
ID26033A (id) Metode penstabilan komposisi bahan farmasi dengan penggunaan khusus dari antioksidan
ATE359268T1 (de) Derivate von n-(phenyl(alkylpiperidin-2- yl)methyl)benzamid, verfahren zu deren herstellung und deren anwendung in therapeutika
ATE461259T1 (de) Flüssigkristallines medium mit monofluor- terphenylverbindungen
ECSP014062A (es) Activadores de fenilamida glucoquinasa para-amina sustituida
DE502004004294D1 (de) Verfahren zur herstellung von pyrrolidin-1,2-dicarbonsäure-1 -(phenyl(-amid))-2-(phenyl(-amid)) derivaten und 1-(phenylcarbamoyl)-pyrrolidin-2-carbonsäurederivate als zwischenprodukte
AR047817A1 (es) Derivados de aril- y heteroarilpiperidincarboxilatos, su preparacion y su aplicacion en terapeutica
MA31346B1 (fr) Formulation liquide injectable de paracetamol
BR0116698A (pt) Composto de modafinila e misturas de ciclodextrina, uso e método de obtenção dos mesmos
TR200301248A2 (tr) Antibiyotik Aktiviteye Sahip Olan Farmasotik Kompozisyonlar.
DOP2006000045A (es) Derivados del (1,5-difenil-1h-pirazol-3-il oxadiazol, su preparacion y su aplicacion en terapeutica
ATE88697T1 (de) E-isomere von n alpha-(2-cyan-2-alkoximinoacetyl)-amino-s|urederivaten und -peptiden.
CO6150166A2 (es) Nuevos derivados de [1,3]tiazolo[4,5-d]pirimidin-2-(3h)-amina 5,7-disustituidos y su uso en terapia
CY1110613T1 (el) Υποκατεστημενες θειαζολες και η χρησιμοποιηση τους για την παρασκευη φαρμακων
ECSP078009A (es) Derivados del 4,5-diarilpirrol, su preparación y su aplicación en terapéutica
ES472448A1 (es) Procedimiento para la preparacion de nuevas amidas de acidosn-i-(3-benzoilpropil)-4-piperidil)-sulfonicos.
NO20070832L (no) Farmasoytiske preparat av piperazinderivater.
BRPI0912551A8 (pt) Compostos para tingimento de queratina, composições para tingimento de queratina contendo os ditos compopstos, e uso dos mesmos
ATE522806T1 (de) Verfahren zum reduzieren der sauerstoffverlustrate aus wässrigen lösungen
ATE336901T1 (de) Verwendung eines akariziden pulvers
ATE194912T1 (de) Mittel zur vorsorge und heilung von typ i allergischen krankheiten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties